Evidence map›Paper›PMID 42026421›Full record

Trial reportMolecular imaging and biology2026

Quantitative [

Elisabeth Kirkeby Lysvik, Andreas Julius Tulipan, Vilde Drageset Haakensen, Mona-Elisabeth R Revheim, Kyrre Eeg Emblem, Trine Hjørnevik

Registry-linked trialAbstract readClinical Trial, Phase II
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Molecular imaging and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03951142 (Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03951142 phase2unknown statusnot on this map

Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study

TypeinterventionalSponsorKyrre Eeg EmblemRan2019 to 2024Enrolled165ConditionsGlioblastoma, Brain MetastasesArmsLosartan
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elisabeth Kirkeby LysvikDepartment of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Building 20, Gaustad Sykehus, Sognsvannveien 21, 0372, Oslo, Norway. eliski@uio.no.ORCID http://orcid.org/0000-0003-1579-1514
Andreas Julius TulipanDepartment of Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Vilde Drageset HaakensenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Mona-Elisabeth R RevheimInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Kyrre Eeg EmblemDepartment of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Building 20, Gaustad Sykehus, Sognsvannveien 21, 0372, Oslo, Norway.
Trine HjørnevikDepartment of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Building 20, Gaustad Sykehus, Sognsvannveien 21, 0372, Oslo, Norway.

Funding

Helse Sør-Øst RHF 2017073Helse Sør-Øst RHF 2021057HORIZON EUROPE European Research Council 758657-ImPRESSKreftforeningen 261984Kreftforeningen 303249Kreftforeningen 32543Kreftforeningen 325971
6 · The paper itself

Abstract

purposeProstate-specific membrane antigen (PSMA) is expressed in several solid tumours, including brain metastases (BMs) from lung cancer. We investigated quantitative [ PROCEDURES: Eleven patients with BM of NSCLC underwent 95-min dual-time-point dynamic [

results[

conclusion[

trial registrationClinicaltrials.gov, NCT03951142. Registered 5 October 2019, https://clinicaltrials.gov/ct2/show/NCT03951142 . EudraCT no 2018-003229-27. Registered 26 February 2019, https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003229-27/NO .

Indexed as

Brain NeoplasmsCarcinoma, Non-Small-Cell LungLung NeoplasmsNiacinamideOligopeptidesPositron-Emission TomographyPositron Emission Tomography Computed TomographyAgedFemaleHumansMaleMiddle AgedTreatment OutcomeNiacinamideOligopeptidesPSMA-1007Brain metastasisDynamic PETLung cancerPatlakPSMA

Identifiers

PMID42026421
PMCPMC13337793

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.